Chengxi Liu
- Co-authors
- Wei ChenDechang LiYangyang SunLei YuWeiren HuangSheng‐ce TaoHe‐wei JiangShujuan Guo
- Topics
- SARS-CoV-2 and COVID-19 Research (2 papers)Sirtuins and Resveratrol in Medicine (2 papers)Neuroscience and Neuropharmacology Research (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Chengxi Liu
14 papers receiving 432 citations
Peers
Comparison fields: 5 of 76
- Molecular Biology 296
- Biomedical Engineering 102
- Infectious Diseases 80
- Plant Science 55
- Cognitive Neuroscience 37
Countries citing papers authored by Chengxi Liu
This map shows the geographic impact of Chengxi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengxi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengxi Liu more than expected).
Fields of papers citing papers by Chengxi Liu
This network shows the impact of papers produced by Chengxi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengxi Liu. The network helps show where Chengxi Liu may publish in the future.
Co-authorship network of co-authors of Chengxi Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Chengxi Liu. A scholar is included among the top collaborators of Chengxi Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengxi Liu. Chengxi Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 6 | |
| 4 | 12 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 171 | |
| 8 | 39 | |
| 9 | 32 | |
| 10 | 8 | |
| 11 | 2 | |
| 12 | 39 | |
| 13 | 45 | |
| 14 | 13 | |
| 15 | 14 | |
| 16 | 50 |
About Chengxi Liu
Chengxi Liu is a scholar working on Geriatrics and Gerontology, Gastroenterology and Microbiology, having authored 16 papers that have together received 435 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (2 papers), Sirtuins and Resveratrol in Medicine (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). The work is most often cited by research in Microbiology (29 citations), Infectious Diseases (80 citations) and Molecular Biology (296 citations). Chengxi Liu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Wei Chen, Dechang Li, Yangyang Sun, Lei Yu, Weiren Huang, Sheng‐ce Tao, He‐wei Jiang, Shujuan Guo, Litao Yang and Ning Shao. Their work appears in journals such as Journal of Biological Chemistry, The EMBO Journal and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.